Before revision: Hans Klingemann and Sally Arai completed the US trial at Rush University Medical Center (Chicago) in renal cell and melanoma patients ,Arai, S., et al.
After revision: in 2008Hans Klingemann and Sally Arai completed the US trial at Rush University Medical Center (Chicago) in renal cell and melanoma patients ,Arai, S., et al.